International Waldenstrom’s Macroglobulinemia Foundation

Language

International Waldenstrom’s Macroglobulinemia Foundation

Language

News

McKesson Specialty Health supports a clinical trials program through US Oncology Research that works with physicians to try to help patients enroll in clinical trials right in their own communities.

Recently, McKesson Specialty Health published its own “story of hope” regarding a successful clinical trial experience with a 91-year-old WM patient.  The article includes insights from the patient, her doctor, and IWMF President Carl Harrington.  You can read the article here.

About US Oncology Research

US Oncology Research is part of the US Oncology Network, one of the US’s largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. As a physician-led organization, it unites like-minded physicians and clinicians around a common vision of improving patient outcomes and quality of life. The US Oncology Network is supported by McKesson Specialty Health, a division of McKesson Corporation focused on empowering a vibrant and sustainable community patient care delivery system.